Taken together, our findings emphasize the critical role of the EF hand-S2–S3 loop interaction in Ca2+/Mg2+-dependent inhibition of RyR1 and provide insights into potential therapeutic strategies targeting this domain interaction for the treatment of skeletal myopathies. The gene discussed is RYR1; the disease is Skeletal myopathy.